Clinical Trials Browser

tumor necrosis factor-alpha, CNGRC fusion protein, human × Gastrointestinal × Clear all

NCT00483080 2019-01-16

Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00484211 2014-05-30

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT00675012 2014-05-30

NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms

NCT00098943 2012-09-24

NGR-TNF in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

CNSEndocrineGastrointestinalGenitourinaryHead & Neck

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Renal Cell, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Parathyroid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic